Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.
JAMA. 2016 Dec 20;316(23):2495-2503. doi: 10.1001/jama.2016.18189.
JAMA. 2016.
PMID: 27997653
Clinical Trial.
Helicase-primase inhibitor pritelivir for HSV-2 infection.
Wald A, Corey L, Timmler B, Magaret A, Warren T, Tyring S, Johnston C, Kriesel J, Fife K, Galitz L, Stoelben S, Huang ML, Selke S, Stobernack HP, Ruebsamen-Schaeff H, Birkmann A.
Wald A, et al. Among authors: timmler b.
N Engl J Med. 2014 Jan 16;370(3):201-10. doi: 10.1056/NEJMoa1301150.
N Engl J Med. 2014.
PMID: 24428466
Free article.
Clinical Trial.
Item in Clipboard
Mathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomes.
Schiffer JT, Swan DA, Magaret A, Corey L, Wald A, Ossig J, Ruebsamen-Schaeff H, Stoelben S, Timmler B, Zimmermann H, Melhem MR, Van Wart SA, Rubino CM, Birkmann A.
Schiffer JT, et al. Among authors: timmler b.
Sci Transl Med. 2016 Feb 3;8(324):324ra15. doi: 10.1126/scitranslmed.aad6654.
Sci Transl Med. 2016.
PMID: 26843190
Free PMC article.
Item in Clipboard
No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy.
Edlefsen PT, Birkmann A, Huang ML, Magaret CA, Kee JJ, Diem K, Goldner T, Timmler B, Stoelben S, Ruebsamen-Schaeff H, Zimmermann H, Warren T, Wald A, Corey L.
Edlefsen PT, et al. Among authors: timmler b.
J Infect Dis. 2016 Jul 15;214(2):258-64. doi: 10.1093/infdis/jiw129. Epub 2016 Apr 7.
J Infect Dis. 2016.
PMID: 27056950
Free PMC article.
Clinical Trial.
Item in Clipboard
Discovery, Chemistry, and Preclinical Development of Pritelivir, a Novel Treatment Option for Acyclovir-Resistant Herpes Simplex Virus Infections.
Birkmann A, Bonsmann S, Kropeit D, Pfaff T, Rangaraju M, Sumner M, Timmler B, Zimmermann H, Buschmann H, Ruebsamen-Schaeff H.
Birkmann A, et al. Among authors: timmler b.
J Med Chem. 2022 Oct 27;65(20):13614-13628. doi: 10.1021/acs.jmedchem.2c00668. Epub 2022 Oct 6.
J Med Chem. 2022.
PMID: 36202389
Free PMC article.
Item in Clipboard
A Multicenter Assessment of the Outcomes and Toxicities of Foscarnet for Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex in Immunocompromised Patients.
Hammond SP, Rangaraju M, Sumner M, Timmler B, Chandrasekar P, Avery RK.
Hammond SP, et al. Among authors: timmler b.
Open Forum Infect Dis. 2024 Feb 5;11(3):ofae046. doi: 10.1093/ofid/ofae046. eCollection 2024 Mar.
Open Forum Infect Dis. 2024.
PMID: 38444818
Free PMC article.
Item in Clipboard
Cite
Cite